Koschmann et al examined the effect of loss of ATRX (Alpha Thalassemia/Mental Retardation Syndrome X-Linked), which is often concurrent with TP53 mutation in gliomas using the SB system. This evidence concerns the gene TP53 and central nervous system cancer.